Skip to main content
. Author manuscript; available in PMC: 2014 Mar 25.
Published in final edited form as: Chem Biol Interact. 2012 Nov 2;203(1):226–230. doi: 10.1016/j.cbi.2012.10.018

Table 2.

Inhibition of carboxylesterases by cholinesterase inhibitors.

Inhibitor IC50 (μM)
hCE1 hiCE AChE BChE
Benzil 0.37 ± 0.04 0.33 ± 0.03 >100 >100
Tolserine >100 >100 1.4 ± 0.1 53.1 ± 20.1
Phenethylcymserine 20.5 ± 10.4 5.6 ± 2.7 1.0 ± 0.2 0.51 ± 0.06
Donepezil >100 >100 0.022 ± 0.005 7.6 ± 1.3
Tacrine >100 >100 0.079 ± 0.002 0.034 ± 0.001
Rivastigmine >100 >100 299 ± 24.6 280 ± 110
Galantamine >100 >100 1.2 ± 0.4 21.7 ± 4.3
Bis(7)-tacrine 40.5 ± 22.0 23.7 ± 3.5 0.0011 ± 0.0001 0.033 ± 0.003
Acridine >100 >100 252 ± 80.9 6.9 ± 1.4
ACMA 111 ± 54.5 28.4 ± 11.4 2.0 ± 0.2 2.5 ± 0.9
DEA 99.3 ± 32.0 41.6 ± 15.2 6.9 ± 0.7 2.4 ± 0.5
HHS Vulnerability Disclosure